» Articles » PMID: 37505061

Multichannel Recovery Potential with Activated Autologous Intraovarian Platelet-Rich Plasma and Its Derivatives

Overview
Specialty Pharmacology
Date 2023 Jul 28
PMID 37505061
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-rich plasma (PRP) is an 'orthobiologic' with recognized roles in plastic surgery, musculoskeletal disorders, dentistry, dermatology, and more recently, 'ovarian rejuvenation'. Intraovarian PRP involves a complex secretome discharged after platelet activation, comprising multiple cytokine mediators delivered surgically to older or inactive ovarian tissue. Loss of oocyte meiotic fidelity and impaired fertilization accompanying advanced maternal age are already managed by IVF, but only with eggs provided by younger donors. However, if the observed effect of rectifying embryo ploidy error can be proven beyond case reports and small series, activated PRP (or its condensed plasma cytokines) would deliver a welcome therapeutic disruption that is difficult to overstate. Because shortcomings in ovarian function are presently addressed mainly by pharmacological approaches (i.e., via recombinant gonadotropins, GnRH analogs, or luteal support), autologous PRP would represent an unusual departure from these interventions. Given the diversity of platelet cargo proteins, the target response of intraovarian PRP is probably not confined to oocytes or follicles. For example, PRP manipulates signal networks driving improved perfusion, HOX regulation, N-glycan post-translational modification, adjustment of voltage-gated ion channels, telomere stabilization, optimization of SIRT3, and ribosome and mitochondria recovery in older oocytes. While multichannel signals operating on various pathways are not unique to reproductive biology, in intraovarian PRP this feature has received little study and may help explain why its standardization has been difficult. Against this background, our report examines the research themes considered most likely to shape clinical practice.

References
1.
Wang S, Liu X, Kang Z, Wang Y . Platelet-rich plasma promotes peripheral nerve regeneration after sciatic nerve injury. Neural Regen Res. 2022; 18(2):375-381. PMC: 9396478. DOI: 10.4103/1673-5374.346461. View

2.
Bousquet P, Sandvik J, Arntzen M, Edin N, Christoffersen S, Krengel U . Hypoxia Strongly Affects Mitochondrial Ribosomal Proteins and Translocases, as Shown by Quantitative Proteomics of HeLa Cells. Int J Proteomics. 2015; 2015:678527. PMC: 4572459. DOI: 10.1155/2015/678527. View

3.
Zhang Y, Huang Q, Cheng J, Nishi Y, Yanase T, Huang H . Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells. Reprod Biol Endocrinol. 2010; 8:61. PMC: 2904782. DOI: 10.1186/1477-7827-8-61. View

4.
Bors S, Dascalu D, Bors A, Fahmy H, Kandil O, Abdoon A . Intraovarian Injection of Reconstituted Lyophilized Growth-Promoting Factor Extracted from Horse Blood Platelets (L-GF) Increases Oocytes Recovery and In Vitro Embryo Production in Holstein Cows. Animals (Basel). 2022; 12(19). PMC: 9559501. DOI: 10.3390/ani12192618. View

5.
Olson M, Dundr M . The moving parts of the nucleolus. Histochem Cell Biol. 2005; 123(3):203-16. DOI: 10.1007/s00418-005-0754-9. View